These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15404328)

  • 21. [Plasma donor of the AB group].
    KRAMARENKO EU
    Khirurgiia (Mosk); 1946; (8):35-7. PubMed ID: 20283323
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet transfusion in an infant leading to formation of anti-D: implications for immunoprophylaxis.
    Haspel RL; Walsh L; Sloan SR
    Transfusion; 2004 May; 44(5):747-9. PubMed ID: 15104657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of pregnancy complicated by anti-hrB/anti-HrB.
    Win N; Needs M; Tillyer L
    Immunohematology; 2007; 23(4):143-5. PubMed ID: 18284303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serologic considerations in donor-specific transfusion therapy for kidney transplantation.
    Schweizer R; Bow L; Generas D; Bartus S
    Transplant Proc; 1982 Jun; 14(2):374-7. PubMed ID: 6810522
    [No Abstract]   [Full Text] [Related]  

  • 25. The frequency of the occurrence of anti-D-B (anti-RhB) in anti-D(anti-Rh) sera.
    WARREN JK
    Vox Sang; 1962; 7():381-3. PubMed ID: 14005041
    [No Abstract]   [Full Text] [Related]  

  • 26. INHIBITION OF AN ANTI-D BY A NORMAL SERUM FACTOR.
    FREIESLEBEN F; JENSEN KG; HANSEN BL
    Sangre (Barc); 1964; 61():123-6. PubMed ID: 14214870
    [No Abstract]   [Full Text] [Related]  

  • 27. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
    Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
    Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients.
    Cid J; Carbassé G; Pereira A; Sanz C; Mazzara R; Escolar G; Lozano M
    Transfusion; 2011 Jun; 51(6):1163-9. PubMed ID: 21126258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Examination of blood donors; contribution to the physiology of the donor].
    BILEK O; BILKOVA L; KUBIKOVA A; TOVAREK Z
    Z Gesamte Inn Med; 1956 May; 11(10):469-72. PubMed ID: 13353310
    [No Abstract]   [Full Text] [Related]  

  • 30. Production of a blocking anti-D antibody by injection of Du red cells.
    CARRIERE M; RUFFIE J
    Br Med J; 1951 Dec; 2(4747):1564-5. PubMed ID: 14879153
    [No Abstract]   [Full Text] [Related]  

  • 31. Blood donor service for a rural community.
    TYMER MR; PATTERSON R
    Rocky Mt Med J; 1948 Mar; 45(3):215. PubMed ID: 18903052
    [No Abstract]   [Full Text] [Related]  

  • 32. [The epidemiology, clinical aspects, immunology and morphology of non-A, non-B hepatitis].
    Renger F; Porst H; Frank KH; Kunze D; Hinkel GK
    Cesk Gastroenterol Vyz; 1982 Jan; 36(1):1-8. PubMed ID: 6277519
    [No Abstract]   [Full Text] [Related]  

  • 33. Passenger lymphocyte syndrome with or without immune hemolytic anemia in all Rh-positive recipients of lungs from rhesus alloimmunized donors: three new cases and a review of the literature.
    Cserti-Gazdewich CM; Waddell TK; Singer LG; Chaparro C; Pendergrast JM; Hawes J; denHollander N; Tinckam K; Keshavjee S
    Transfus Med Rev; 2009 Apr; 23(2):134-45. PubMed ID: 19304114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INHIBITION OF AN ANTI-D BY A NORMAL SERUM FACTOR.
    FREIESLEBEN E; JENSEN KG
    Vox Sang; 1964; 9():65-9. PubMed ID: 14115409
    [No Abstract]   [Full Text] [Related]  

  • 35. Experiences with the use of universal donor blood and pooled plasma.
    EMERSON CP
    Bull New Engl Med Cent; 1946 Oct; 8(5):201-3. PubMed ID: 20285238
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppressive protocols for transplantation and certain hematologic malignancies can prevent the primary immune response to the D blood group antigen.
    Seager A; Sandler SG
    Immunohematology; 2013; 29(3):110-4. PubMed ID: 24325172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Secondary immune blood transfusion shock in calves due to the donor immune erythrocyte isoantibodies].
    Golemanov D
    Vet Med Nauki; 1980; 17(8):72-8. PubMed ID: 7269224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of the isoantigen A2 and immune anti-A1 antibodies in transfusiology].
    Dashkova NG; Ragimov AA; Asoskova TK
    Anesteziol Reanimatol; 2009; (6):62-5. PubMed ID: 20099652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [FREQUENCY OF ANTI-GM AND ANTI-D SERUMS ESSENTIAL TO THE DETERMINATION OF GM BLOOD GROUPS].
    AUDRAN R
    C R Hebd Seances Acad Sci; 1964 Nov; 259():4183-5. PubMed ID: 14260663
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of transfusion on recipient immune status: relationship to transplantation.
    Kahan BD
    Prog Clin Biol Res; 1985; 182():345-74. PubMed ID: 2994107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.